Navigation Links
MedeAnalytics Releases Analysis of Public Comments on ACO Proposed Rule
Date:6/13/2011

EMERYVILLE, Calif., June 13, 2011 /PRNewswire/ -- MedeAnalytics, a leading provider of healthcare performance management solutions, disseminated today a report which analyzes the leading healthcare constituencies' recommendations on the major factors of the accountable care organization (ACO) economic model as presented in the proposed rule for the Medicare Shared Savings Program.

(Logo:  http://photos.prnewswire.com/prnh/20100621/SF23660LOGO)

The proposed rule was released on March 31, 2011, and the public comment period ended on June 6, 2011. The MedeAnalytics report identifies nine elements of the program that function as the primary drivers of the Medicare ACO business model. In addition, it presents the respective positions on these elements of seven nationally recognized healthcare constituencies: the American Hospital Association, the Federation of American Hospitals, the American Medical Association, the American Medical Group Association, the Medical Group Management Association, America's Health Insurance Plans, and Brookings-Dartmouth.

"While there has been some rhetoric in the media about scrapping the entire ACO program as laid out by the proposed rule, the seven constituent organizations presented recommendations to revise, not repeal, the program," commented Ken Perez, who directs MedeAnalytics' healthcare policy team and serves as the company's senior vice president of marketing.

All seven organizations recommended a significant reduction to the 65 quality measures in the proposed rule (with the 32 measures of the Physician Group Practice Demonstration often cited as a preferred measure set), as well as a gradual phase-in period. A majority of the organizations urged the Centers for Medicare & Medicaid Services (CMS) to make the financial terms of the ACO program more attractive, with calls for a standard, flat Minimum Savings Rate, increases to the maximum shared savings rate, the elimination of withholding of a portion of the earned performance payment by CMS, and creation of a separate model without downside risk.  

To download the complete report, including a table summarizing the recommendations of the seven organizations for the major financial aspects of the proposed rule, visit MedeAnalytics' ACO Resource Center at www.medeanalytics.com/aco.

About MedeAnalytics

Founded in 1994, MedeAnalytics delivers performance management solutions across the healthcare system—including hospitals, physician practices and payers—to ensure accountability and improve financial, operational and clinical outcomes. For more information, visit www.medeanalytics.com.

For more information:
Bruce Lewis
Lewis & Summers Public Relations
(707) 813-1197
bruce@prwebsite.com


'/>"/>
SOURCE MedeAnalytics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ACO Proposed Rule Simplified: MedeAnalytics Releases Comprehensive White Paper
2. Unprecedented international meeting releases preliminary vision for our energy future
3. ClearCanvas Releases First Commercial Version of Widely Used PACS; Integrated RIS/PACS to Follow
4. Announcement - Clontech Laboratories, Inc. Releases the iDimerize™ Cell Signaling and Expression Systems
5. ClearCanvas Releases First Commercial Version of Popular Clinical Radiology Workstation; PACS and RIS to Follow
6. BioLegend Releases Brilliant Violet 421™ Antibody Conjugates For Advanced Flow Cytometry Applications.
7. Clontech Laboratories, Inc. Releases the SMARTer™ Ultra Low RNA Kit for Illumina® Sequencing
8. OriGene Releases Bioactive Full-length Human MTOR Protein
9. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011
10. Waters Releases NuGenesis SDMS 7.1 Validated to Support Windows 7 and Empower 3 CDS
11. OriGene Releases 1500 TrueMAB™ Monoclonal Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... 22, 2017 , ... Baltimore biotech firm, PathSensors, announced that ... in developing and issuing recommendations to grow Maryland's biohealth industry and position the ... , The recommendations are contained in a report from the ...
(Date:5/21/2017)... ... 20, 2017 , ... CNSDose is a genetically driven, clinically ... by finding the right antidepressant faster. CNSDose speeds recovery and reduces side ... personalized approach to treatment. , A peer-reviewed and published, 12-week double-blind ...
(Date:5/18/2017)... Malden, Mass. (PRWEB) , ... May 18, 2017 ... ... completed the procedure on April 28, 2017 at the Prince Of Wales Private ... degenerative cervical disc at level C6-C7. The patient failed conservative treatments prior to ...
(Date:5/18/2017)... ... May 17, 2017 , ... NDA Partners Chairman Carl ... CEO of Eurofins Advantar Laboratories and President of Pharmaceutical Development Business Unit of Cardinal ... at Eurofins and Cardinal Health, he was former Chief Operating Officer at Anaborex, Senior ...
Breaking Biology Technology:
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):